Tempol attenuates atherosclerosis associated with metabolic syndrome via decreased vascular inflammation and NADPH-2 oxidase expression

References

• Fearon IM, Faux SP. Oxidative stress and cardiovascular disease: novel tools give (free) radical insight. J Mol Cell Cardiol 2009;47:372–381.
   PubMed Web of Science ®Google Scholar
• Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol 2003;91:7A–11A.
   PubMed Web of Science ®Google Scholar
• Sorescu D, Szocs K, Griendling KK. NAD(P)H oxidases and their relevance to atherosclerosis. Trends Cardiovasc Med 2001;11:124–131.
   PubMed Web of Science ®Google Scholar
• Muller G, Morawietz H. Nitric oxide, NAD(P)H oxidase and atherosclerosis. Antioxid Redox Signal 2009;11:1711–1731.
   PubMed Web of Science ®Google Scholar
• Collin B, Busseuil D, Zeller M, Perrin C, Barthez O, Duvillard L, et al. Increased superoxide anion production is associated with early atherosclerosis and cardiovascular dysfunctions in a rabbit model. Mol Cell Biochem 2007; 294:225–235.
   PubMed Web of Science ®Google Scholar
• Vendrov AE, Hakim ZS, Madamanchi NR, Rojas M, Madamanchi C, Runge MS. Atherosclerosis is attenuated by limiting oxidant generation in both macrophages and vessel wall cells. Arterioscler Thromb Vasc Biol 2007;27: 2714–2721.
   PubMed Web of Science ®Google Scholar
• Cruzado MC, Risler NR, Miatello RM, Yao G, Schiffrin EL, Touyz RM. Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: Effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation. Am J Hypertens 2005;18:81–87.
   PubMed Web of Science ®Google Scholar
• Busserolles J, Gueux E, Rock E, Mazur A, Rayssiguier Y. High fructose feeding of magnesium deficient rats is associated with increased plasma triglyceride concentration and increased oxidative stress. Magnes Res 2003;16:7–12.
   PubMed Web of Science ®Google Scholar
• Cannizzo B, Lujan A, Estrella N, Lembo C, Cruzado M, Castro C. Insulin resistance promotes early atherosclerosis via increased proinflammatory proteins and oxidative stress in fructose-fed ApoE-KO mice. Exp Diabetes Res 2012; 2012:941304.
   PubMedGoogle Scholar
• Touyz RM, Chen X, Tabet F, Yao G, He G, Quinn MT, et al. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ Res 2002;90:1205–1213.
   PubMed Web of Science ®Google Scholar
• Griendling KK, Sorescu D, Lassegue B, Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 2000; 20:2175–2183.
   PubMed Web of Science ®Google Scholar
• Drummond GR, Selemidis S, Griendling KK, Sobey CG. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov 2011; 10:453–471.
   PubMed Web of Science ®Google Scholar
• Shin MH, Moon YJ, Seo JE, Lee Y, Kim KH, Chung JH. Reactive oxygen species produced by NADPH oxidase, xanthine oxidase, and mitochondrial electron transport system mediate heat shock-induced MMP-1 and MMP-9 expression. Free Radic Biol Med 2008;44:635–645.
   PubMed Web of Science ®Google Scholar
• Poitevin S, Garnotel R, Antonicelli F, Gillery P, Nguyen P. Type I collagen induces tissue factor expression and matrix metalloproteinase 9 production in human primary monocytes through a redox-sensitive pathway. J Thromb Haemost 2008;6:1586–1594.
   PubMed Web of Science ®Google Scholar
• Rizvi AA. Cytokine biomarkers, endothelial inflammation, and atherosclerosis in the metabolic syndrome: emerging concepts. Am J Med Sci 2009;338:310–318.
   PubMed Web of Science ®Google Scholar
• Gimbrone MA Jr, Bevilacqua MP, Cybulsky MI. Endothelial-dependent mechanisms of leukocyte adhesion in inflammation and atherosclerosis. Ann N Y Acad Sci 1990;598:77–85.
   PubMed Web of Science ®Google Scholar
• Guardamagna O, Abello F, Saracco P, Baracco V, Rolfo E, Pirro M. Endothelial activation, inflammation and premature atherosclerosis in children with familial dyslipidemia. Atherosclerosis 2009;207:471–475.
   PubMed Web of Science ®Google Scholar
• Peter K, Weirich U, Nordt TK, Ruef J, Bode C. Soluble vascular cell adhesion molecule-1 (VCAM-1) as potential marker of atherosclerosis. Thromb Haemost 1999;82:38–43.
   PubMedGoogle Scholar
• Nakashima Y, Raines EW, Plump AS, Breslow JL, Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol 1998;18:842–851.
   PubMed Web of Science ®Google Scholar
• Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto AM Jr, Boerwinkle E. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 1997;96:4219–4225.
   PubMed Web of Science ®Google Scholar
• Davies MJ, Gordon JL, Gearing AJ, Pigott R, Woolf N, Katz D, Kyriakopoulos A. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol 1993;171:223–229.
   PubMed Web of Science ®Google Scholar
• Deem TL, Cook-Mills JM. Vascular cell adhesion molecule 1 (VCAM-1) activation of endothelial cell matrix metalloproteinases: role of reactive oxygen species. Blood 2004;104: 2385–2393.
   PubMed Web of Science ®Google Scholar
• Park JG, Ryu SY, Jung IH, Lee YH, Kang KJ, Lee MR, et al. Evaluation of VCAM-1 antibodies as therapeutic agent for atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 2013;2226:3356–3363.
   Google Scholar
• Gamkrelidze M, Mamamtavrishvili N, Bejitashvili N, Sanikidze T, Ratiani L. Role of oxidative stress in pathogenesis of atherosclerosis. Georgian Med News 2008;(163): 54–57.
   PubMedGoogle Scholar
• Koh KK, Oh PC, Quon MJ. Does reversal of oxidative stress and inflammation provide vascular protection?. Cardiovasc Res 2009;81:649–659.
   PubMed Web of Science ®Google Scholar
• Nauseef WM. Biological roles for the NOX family NADPH oxidases. J Biol Chem 2008;283:16961–16965.
   PubMed Web of Science ®Google Scholar
• Delbosc S, Paizanis E, Magous R, Araiz C, Dimo T, Cristol JP, et al. Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat. Atherosclerosis 2005;179:43–49.
   PubMed Web of Science ®Google Scholar
• Wilcox CS. Effects of tempol and redox-cycling nitroxides in models of oxidative stress. Pharmacol Ther 2010;126: 119–145.
   PubMed Web of Science ®Google Scholar
• Giera M, Lingeman H, Niessen WM. Recent advancements in the LC- and GC-based analysis of Malondialdehyde (MDA): a brief overview. Chromatographia 2012;75:433–440.
   PubMed Web of Science ®Google Scholar
• Guzik TJ, West NE, Black E, McDonald D, Ratnatunga C, Pillai R, Channon KM. Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circ Res 2000;86:E85–90.
   PubMed Web of Science ®Google Scholar
• Selemidis S, Sobey CG, Wingler K, Schmidt HH, Drummond GR. NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition. Pharmacol Ther 2008;120:254–291.
   PubMed Web of Science ®Google Scholar
• Barry-Lane PA, Patterson C, van der Merwe M, Hu Z, Holland SM, Yeh ET, Runge MS. p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J Clin Invest 2001;108:1513–1522.
   PubMed Web of Science ®Google Scholar
• Ortiz MC, Manriquez M, Romero J, Juncos L. Antioxidants block angiotensin II-induced increases in blood pressure and endothelin. Hypertension 2001;38:655–659.
   PubMed Web of Science ®Google Scholar
• Chung S, Park CW, Shin SJ, Lim JH, Chung HW, Youn DY, et al. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats. Nephrol Dial Transplant 2010;25:389–399.
   PubMed Web of Science ®Google Scholar
• Park JB, Touyz RM, Chen X, Schiffrin EL. Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats. Am J Hypertens 2002;15:78–84.
   PubMed Web of Science ®Google Scholar
• Jagadeesha DK, Lindley TE, Deleon J, Sharma RV, Miller F, Bhalla RC. Tempol therapy attenuates medial smooth muscle cell apoptosis and neointima formation after balloon catheter injury in carotid artery of diabetic rats. Am J Physiol Heart Circ Physiol 2005;289:H1047–1053.
   Web of Science ®Google Scholar